All these isoforms of uPAR generated by post-translational hydrolytic processing (suPAR DI–D3, suPAR D2–D3, suPAR D1, and GPI-anchored uPAR D2–D3) have been detected in vitro and in vivo, in both healthy and ill subjects, including cancer patients. This evidence concerns the gene PLAUR and cancer.